ViiV AT EACS 2025

We are excited to announce that we will be presenting new data from our innovative HIV treatment and prevention portfolio at the European AIDS Clinical Society Conference (EACS) in Paris, France from 15-18 October 2025.

Our Innovative Portfolio at EACS 2025

Our presentations

We'll be sharing data from 17 abstracts and 22 ViiV-supported abstracts and collaborative studies from our industry leading treatment and prevention portfolio, including 7 oral presentations and 32 poster presentations. Our data will focus on the role of our diverse portfolio in ending the HIV epidemic in Europe and globally.

You can find out more about our data and as well as the full conference programme here

Our events at EACS

Our mission to end the HIV epidemic starts with partnership. At ViiV Healthcare, we’re dedicated to amplifying the voices of people living with HIV and fostering collaboration between communities and healthcare professionals. From events that advance important conversations on HIV innovation to moments where lived experiences are shared and valued, we ensure the community remains at the heart of progress.

  • Our Symposia

    For HCPs only

    The Long-acting Debate: Are We Equipped to End the Epidemic?
    Thursday 16th October | 08:00–09:00 (CEST) | Amphithéâtre Bleu

    The Long-acting Discussion: Linking Evidence, Clinical Cases and Care
    Thursday 16th October | 12:30–14:00 (CEST) | Amphithéâtre Bleu

  • ViiV Healthcare x The Skin Deep {THE AND} Experience

    A unique interactive experience, developed in partnership with The Skin Deep to demonstrate the power of open and honest conversations between healthcare providers and their patients.

    Date: 16th October
    Time: 19:00-20:15 (CEST)
    Location: Le Méridien Paris Arc De Triomphe
    Meeting Room: Mac-Mahon 1+2

RELATED PAGES:

U=U

U=U

U=U is a simple, concise and impactful abbreviation for Undetectable = Untransmittable. It signifies that individuals with HIV, undergoing treatment and maintaining an undetectable viral load, cannot transmit the virus to an HIV-negative partner.

Learn more

Ending HIV

Ending HIV

We can end HIV through continuous innovation, global partnerships and talented people that help us reach the communities that are disproportionately impacted by HIV.

Learn more

HIV Prevention

HIV Prevention

We believe in a comprehensive approach to HIV prevention that considers both medical and non-medical alternatives that are accessible to all. Ideally, a combination of strategies can be effective in reducing the likelihood of HIV transmission.

Learn more

NP-GBL-HVX-WCNT-230025 | October 2025

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.